ALAlexandra Liebmann

Alexandra Liebmann

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Alexandra Liebmann has a total of 64 co-authors. Here are the top co-authors by number of shared publications:

  • Andrea Forschner

    Department of Dermatology, Center for Dermatooncology, University Hospital Tübingen, Tübingen, Germany

    2 shared publications
  • Christopher Schroeder

    Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen, Tübingen, Germany

    2 shared publications
  • Hannah Wild

    Pediatric Hematology and Oncology Children's Hospital, Eberhard‐Karls‐Universität Tübingen Tübingen Germany

    2 shared publications
  • Ines B. Brecht

    Pediatric Hematology and Oncology Children's Hospital, Eberhard‐Karls‐Universität Tübingen Tübingen Germany

    2 shared publications
  • Irina Bonzheim

    Institute of Pathology and Neuropathology, University Hospital Tübingen, Tübingen, Germany

    2 shared publications
  • Michael Abele

    Pediatric Hematology and Oncology Children's Hospital Eberhard‐Karls‐Universität Tübingen Tübingen Germany

    2 shared publications

Latest Publications

  • Open Access

    Prenatal Phenotypic Features of Five Fetal Cases With RNU4ATAC ‐Associated Microcephalic Osteodysplastic Primordial Dwarfism Type I

    by Alexandra Liebmann, Tanja Richter, Nevena Krstić, Markus Hoopmann, Karl Oliver Kagan, Lena‐Sophie Menig‐Benzig, Simone Olivieri, Olaf Riess, Andreas Dufke

    Objective: To present the prenatal sonographic features, genomic findings, and pregnancy outcomes of fetuses with biallelic pathogenic RNU4ATAC variants linked to microcephalic osteodysplastic primordial dwarfism type I (MOPD1). Methods: This retrospective case series includes five prenatal cases with MOPD1. Diagnoses were established by prenatal ultrasound and genetic testing. Genome sequencing (GS) or targeted exome sequencing (ES) detected the variants either prenatally or after termination of pregnancy (TOP). Clinical data including parental demographics, ultrasound findings, and pregnancy outcomes were collected. Results: All fetuses presented with consistent anomalies on ultrasound including intrauterine growth restriction (IUGR), microcephaly, agenesis of the corpus callosum (ACC), intracranial cysts, lissencephaly, and micrognathia. IUGR was the earliest anomaly detected in all five cases. Prenatal ultrasound findings suggestive of skeletal dysplasia were identified in one case. All cases carried biallelic pathogenic RNU4ATAC variants associated with MOPD1. TOP was chosen in four cases. One fetus was delivered at 39 + 1 weeks with genetic diagnosis confirmed at 27 weeks. Conclusion: IUGR, microcephaly and ACC can be detected in fetuses with MOPD1 at around 18 weeks of gestation. Interestingly, skeletal dysplasia was not a consistent prenatal finding. Variants in the non‐coding RNU4ATAC gene need to be detected by GS or targeted approaches beyond standard ES.

  • Open Access

    Colorectal Carcinoma in Childhood and Adolescence: Microsatellite Instability Correlates With a Favorable Prognosis

    by Hannah Wild, Alexandra Liebmann, Lucas Maennel, Linda Maschke, Andreas Block, Leo Kager, Udo Kontny, Abbas Agaimy, Michaela Kuhlen, Antje Redlich, et al.

    Background: Colorectal cancer (CRC) accounts for 10% of cancer cases worldwide; however, pediatric CRC is extremely rare, with an annual incidence of one to two cases per million. Microsatellite instability (MSI) has been shown to play a relevant prognostic role in adult CRC. Corresponding data for pediatric CRC are lacking. This study examines MSI in pediatric CRC.Procedure: Patient‐, tumor‐, and treatment‐related data of patients less than 18 years with CRC enrolled in the German Registry for Rare Pediatric Tumors (STEP) between 2005 and 2023 were analyzed and compared with data on patients less than 30 years with CRC and known MSI status from the Surveillance, Epidemiology, and End Results Program (SEER).Results: Forty‐one patients with CRC were recorded in STEP. Cancer predisposition syndromes were identified in 52% of tested cases, especially in CRC with MSI (84.6%). The SEER cohort included 803 CRC patients under 30 years, 52 of whom were under 20 years. Most cases were at an advanced stage at diagnosis, with localized disease being rare (STEP: 4.9%, SEER: 16.4%). The 5‐year overall survival (OS) of STEP patients was 47.9% ± 9.7%. MSI was observed in 37.5% (STEP) and 32.7% (SEER p = 0.007).Conclusions: While pediatric CRCs overall more often demonstrate advanced stages, unfavorable histology, and a poorer prognosis than adult CRC, MSI is more common in pediatric CRC and is associated with superior survival.


  • Open Access

    UV-radiation and MC1R germline mutations are risk factors for the development of conventional and spitzoid melanomas in children and adolescents

    by Alexandra Liebmann, Jakob Admard, Sorin Armeanu-Ebinger, Hannah Wild, Michael Abele, Axel Gschwind, Olga Seibel-Kelemen, Christian Seitz, Irina Bonzheim, Olaf Riess, et al.


  • Germline findings in patients with advanced malignancies screened with paired blood–tumour testing for personalised treatment approaches

    by Cristiana Roggia, Sorin Armeanu-Ebinger, Axel Gschwind, Olga Seibel-Kelemen, Sonja Hertler, Ulrike Faust, Alexandra Liebmann, Tobias B. Haack, Manuela Neumann, Irina Bonzheim, et al.